Breakthrough for Diabetic Foot Screening in Germany – Top-Ranked Diabetes Clinic Purchases VibroSense Meter ® II
The Diabetes Clinic Herz und Diabetescentrum Nordrhein-Westfalen (HDZ NRW) has purchased VibroSense Meter® II and Diabetic Foot Screening after completed evaluation.
The clinic has been evaluating VibroSense Meter® II and the application Diabetic Foot Screening with a stated goal of purchasing the instrument after the evaluation is completed, provided that the instrument meets defined requirements. The order value is 16 500 EUR including an annual recurring software license fee of 2000 EUR.
The diabetes clinic at HDZ NRW is a highly ranked clinic at the university hospital in Bochum in Germany. In recent years (2020 and 2022), the clinic has received the highly regarded award "5-Sterne-Auszeichnung" awarded by the institute "Bundesverband Klinischer Diabetes-Einrichtungen" (BKvD).
"The order from HDZ NRW is a major and important breakthrough for VibroSense. We have invested in building knowledge and establishing a thorough plan for the German market, and the purchase of our product is proof that we have taken a big step forward in Germany. With several ongoing discussions, with other interesting clinics, it means a lot that we now may deliver our first instrument to HDZ NRW. Our plan for Germany is firm and we feel both optimistic and strengthened for the future," says Hans Wallin, CEO of VibroSense Dynamics AB.
About Diabetes Herz und Diabetescentrum in NRW Bad Oeynhausen
The Heart and Diabetes Center North Rhine-Westphalia (HDZ NRW) is a university clinic at the Ruhr University in Bochum and a leading international center for the treatment of heart, circulatory and diabetes diseases. With 35,000 heart and diabetes patients per year, of which 14,500 are inpatients, HDZ NRW is one of the largest and most modern clinical centers of its kind in Europe. The diabetes clinic at HDZ NRW has around 2,000 diabetes patients with all types of diabetes and its complications who are treated at the clinic every year. In addition to the treatment of cardiovascular diseases as well as endocrinology and gastroenterology, the diabetes center specializes in the treatment of nerve damage and circulatory disorders, including the care of diabetic foot syndrome.
Contact
Hans Wallin, CEO VibroSense Dynamics AB
Tel: +46 40 88 026
Email: info@vibrosense.com
"The new Gold Standard for reliable
detection of nerve damage"
About VibroSense Dynamics AB (publ)
VibroSense Dynamics AB (publ) develops and sells medical technology products and services for diagnostic support for nerve damage in the hands and feet. The method involves measuring and quantifying the ability to feel vibrations at several frequencies. The company's customers are diabetes clinics, occupational health care, hospitals, health centers and researchers.
Our vision is that the company's products should be a standard instrument in all neurological examinations to detect early signs of changes in sensation so that patients and their caregivers can implement preventive measures that prevent, reduce or delay the onset of nerve damage in the hands and feet.